Hanna Tokkie schreef:
Pharming Group N.V. Acquires Licenses to Fibrinogen Patents
Pharming Group N.V announced that it has obtained exclusive licenses on recombinant fibrinogen for all indications in various territories, including North America, Europe and Japan, from GTC Biotherapeutics Inc (GTC). The licenses are for recently issued patents owned by the American Red Cross, Virginia Tech Intellectual Properties Inc and the University of North Carolina on the production of recombinant fibrinogen in milk of transgenic animals which are licensed to GTC from ProGenetics, LLC. The license agreement includes an upfront payment to GTC of approximately EUR 350,000 and a royalty on commercial sales of recombinant human fibrinogen.